Relationship Between Duration of Type 2 Diabetes and Effectiveness of DPP-4 Inhibitor Versus Sulfonylurea as Add-on Therapy: A Post Hoc Analysis

INTRODUCTION: To assess the impact of duration of type 2 diabetes on glucose-lowering effectiveness of the dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin versus sulfonylureas (SUs) in a real-life setting. METHODS: Data were extracted from the large 1-year, observational EDGE study (N = 45,868...

Descripción completa

Detalles Bibliográficos
Autores principales: Brath, Helmut, Paldánius, Päivi M., Bader, Giovanni, Mathieu, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544613/
https://www.ncbi.nlm.nih.gov/pubmed/28631242
http://dx.doi.org/10.1007/s13300-017-0276-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544613/
https://www.ncbi.nlm.nih.gov/pubmed/28631242
http://dx.doi.org/10.1007/s13300-017-0276-1

Ejemplares similares